You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mycobacterial Infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Expectorated and Induced Sputum and Pharyngeal Swabs for

Completed
  • Myobacterium Infections, Nontuberculous
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)

    Not yet recruiting
    • Mycobacterium Avium Complex Pulmonary Disease
    • (no location specified)
    May 15, 2023

    Transmission and Acquisition of Nontuberculous Mycobacteria

    Recruiting
    • Nontuberculous Mycobacterial Pulmonary Infection
    • +3 more
    • Epidemiologic investigation
    • Denver, Colorado
      National Jewish Health
    Dec 1, 2023

    Mycobacterial and Opportunistic Infections in HIV-Negative Thai

    Active, not recruiting
    • Non-Tuberculous Mycobacteria
    • +2 more
      • Taiwan, China
        National Taiwan University
      Aug 18, 2022

      Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) Trial in United States (Molgramostim nebulizer solution, PARI

      Terminated
      Has Results
      • Mycobacterium Infections, Nontuberculous
      • Cystic Fibrosis (CF)
      • Molgramostim nebulizer solution
      • PARI eFlow nebulizer system
      • Denver, Colorado
      • +4 more
      Oct 10, 2021

      Nontuberculous Mycobacterium Infection Trial in Portland, Charleston (gNO)

      Completed
      Has Results
      • Nontuberculous Mycobacterium Infection
      • Portland, Oregon
      • +1 more
      May 17, 2021

      Healthy, Latent Tuberculosis Infection (LTBI) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Tuberculin

      Recruiting
      • Healthy
      • Latent Tuberculosis Infection (LTBI)
      • Tuberculin Purified Protein Derivative
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jul 22, 2022

      PK and PD of Antibiotics for Treatment of Mycobacterium

      Not yet recruiting
      • Nontuberculous Mycobacterial Pulmonary Infection
      • Measuring PK and PD indices in patients who receive conventional treatment
      • (no location specified)
      Dec 22, 2022

      Prospective Healthcare-Associated Links in Transmission of

      Enrolling by invitation
      • Cystic Fibrosis
      • Nontuberculous Mycobacterial Pulmonary Infection
        • Denver, Colorado
          National Jewish Health
        Jan 6, 2023

        Mycobacterium Abscessus Infection in Chronic Lung Disease and

        Enrolling by invitation
        • Mycobacterium Abscessus Infection
        • +2 more
        • Appropriate treatment
        • Pathum Wan, Bangkok, Thailand
          King Chulalongkorn Memorial Hospital
        Aug 31, 2022

        Cystic Fibrosis Trial in Aurora (Ethambutol, Rifampin, Azithromycin)

        Completed
        Has Results
        • Cystic Fibrosis
        • Aurora, Colorado
          Children's Hospital Colroado
        Jan 20, 2021

        Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto

        Recruiting
        • Nontuberculous Mycobacterial Lung Disease
        • Nontuberculous Mycobacterium Infection
        • Hypertonic saline
        • +3 more
        • New York, New York
        • +2 more
        Jan 27, 2023

        Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease Trial in

        Recruiting
        • Mycobacterium Infections, Nontuberculous
        • +3 more
        • Omadacycline Oral Tablet
        • Placebo
        • Birmingham, Alabama
        • +20 more
        Jan 11, 2023

        Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Trial (Placebo, SPR720 500 mg, SPR720 1000 mg)

        Not yet recruiting
        • Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
        • Placebo
        • +2 more
        • (no location specified)
        Aug 9, 2022

        Mycobacterium Infections, Nontuberculous Trial in Australia, United Kingdom (Inhaled molgramostim)

        Completed
        • Mycobacterium Infections, Nontuberculous
        • Inhaled molgramostim
        • Concord, New South Wales, Australia
        • +4 more
        Mar 23, 2021

        Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Bacterial Infections Trial in Worldwide (Individualised treatment

        Recruiting
        • Tuberculosis, Pulmonary
        • +3 more
        • Individualised treatment duration based on RNA transcriptomic model
        • Borstel, Schleswig-Holstein, Germany
        • +4 more
        Apr 7, 2021

        Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)

        Recruiting
        • Non-Tuberculous Mycobacterial Pneumonia
        • +4 more
        • LungFit
        • Greenslopes, Queensland, Australia
          Gallipoli Medical Research Foundation
        Dec 24, 2020

        Study of Mycobacterial Infections

        Recruiting
        • Mycobacterium Infections
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        Performance Evaluation of the VIDAS TB-IGRA Assay.

        Completed
        • Active Tuberculosis
        • +2 more
        • Blood draw and IGRA test
        • Palo Alto, California
        • +23 more
        Jul 14, 2021

        Self-test and Self-alert Mobile Applet in Detecting Susceptible

        Completed
        • Susceptibility to Viral and Mycobacterial Infection
        • mobile internet survey on self-test
        • Beijing, Beijing, China
          Beijing Tsinghua Changgung Hospital
        Jul 5, 2020

        Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

        Active, not recruiting
        • Mycobacterium Infections, Nontuberculous
        • Birmingham, Alabama
        • +110 more
        Jan 23, 2023

        Non-Tuberculous Mycobacterial Pneumonia Trial in Vancouver (Nitric Oxide gas at 160ppm)

        Completed
        • Non-Tuberculous Mycobacterial Pneumonia
        • Nitric Oxide gas at 160ppm
        • Vancouver, British Columbia, Canada
          Gordon Leslie Diamond Health Care Centre
        Jul 27, 2020

        Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)

        Completed
        Has Results
        • Mycobacterium Infections, Nontuberculous
        • LAI (Liposomal Amikacin for Inhalation) 590 mg
        • (no location specified)
        Apr 22, 2020

        Drug Exposure and Minimum Inhibitory Concentration in Treatment

        Not yet recruiting
        • Mycobacterium Avium Complex
        • +3 more
        • Drug exposure
        • Shanghai, China
          Shanghai Pulmonary Hospital
        Apr 10, 2023

        Non-Tuberculous Mycobacterial (NTM) Infections Trial in Canada, United States (Lamprene®/Clofazimine)

        Available
        • Non-Tuberculous Mycobacterial (NTM) Infections
        • (no location specified)
        Dec 14, 2022